Enveric Biosciences, Inc.
ENVB
$5.90
$0.081.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.76M | 2.85M | 4.29M | 2.24M | 3.11M |
| Total Receivables | -- | -- | -- | -- | 17.80K |
| Inventory | 59.10K | 65.40K | -- | -- | -- |
| Prepaid Expenses | 311.10K | 389.00K | 540.00K | 260.50K | 454.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 37.70K | 3.20K | 400.00 | 233.10K | 754.60K |
| Total Current Assets | 4.17M | 3.31M | 4.83M | 2.73M | 4.34M |
|
|
|||||
| Total Current Assets | 4.17M | 3.31M | 4.83M | 2.73M | 4.34M |
| Net Property, Plant & Equipment | 196.50K | 241.10K | 267.30K | 305.80K | 367.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 42.20K | 84.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.36M | 3.55M | 5.10M | 3.08M | 4.79M |
|
|
|||||
| Total Accounts Payable | 683.70K | 1.04M | 669.20K | 521.70K | 576.30K |
| Total Accrued Expenses | 222.20K | 322.70K | 497.20K | 946.90K | 253.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 18.00K | 21.10K | 9.70K |
| Total Other Current Liabilities | -- | -- | 18.00K | 21.10K | 9.70K |
| Total Current Liabilities | 905.90K | 1.36M | 1.18M | 1.49M | 839.20K |
|
|
|||||
| Total Current Liabilities | 905.90K | 1.36M | 1.18M | 1.49M | 839.20K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 905.90K | 1.36M | 1.18M | 1.49M | 839.20K |
|
|
|||||
| Common Stock & APIC | 116.69M | 113.54M | 112.78M | 108.26M | 107.41M |
| Retained Earnings | -112.65M | -110.78M | -108.26M | -106.07M | -102.92M |
| Treasury Stock & Other | -580.90K | -573.50K | -598.00K | -594.50K | -535.00K |
| Total Common Equity | 3.46M | 2.18M | 3.92M | 1.59M | 3.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.46M | 2.18M | 3.92M | 1.59M | 3.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.46M | 2.18M | 3.92M | 1.59M | 3.95M |
|
|
|||||